By Gilead Sciences | September 27, 2017China’s FDA Approves Gilead’s Sovaldi to Treat Chronic HCV Infection
By Gilead Sciences | August 11, 2017FDA Grants Priority Review to Gilead’s Fixed-Dose BIC/FTC/TAF HIV Treatment